View in EDS

FOLFOXIRI plus bevacizumab as conversion-therapy for liver metastases in colorectal cancer: A necessity?

Saved in:
Bibliographic Details
Title: FOLFOXIRI plus bevacizumab as conversion-therapy for liver metastases in colorectal cancer: A necessity?
Authors: Modest, D.P.1,2,3,4 dominik.modest@med.uni-muenchen.de, Neumann, U.P.1,2,3,4, Pratschke, J.1,2,3,4
Source: European Journal of Cancer. Mar2017, Vol. 73, p71-73. 3p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first